The role of the Pharmaceuticals and Medical Devices Agency and healthcare professionals in post-marketing safety-Reference-Cited by-同舟云学术

The role of the Pharmaceuticals and Medical Devices Agency and healthcare professionals in post-marketing safety

Published:2014-03-22 Issue:2 Volume:7 Page:103-107
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Mori Kazuhiko,Watanabe Meguru,Horiuchi Naoya,Tamura Atsushi,Kutsumi Hiromu

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12328-014-0474-6.pdf

Reference14 articles.

1. Iyakuhin Kanren Jouhou. Pharmaceuticals and Medical Devices Agency. http://www.info.pmda.go.jp/info/syounin_index.html . Accessed 20 February 2014 (In Japanese).

2. Iryoukiki Kanren Jouhou. Pharmaceuticals and Medical Devices Agency. http://www.info.pmda.go.jp/info/syounin_kiki_index.html . Accessed 20 February 2014 (In Japanese).

3. Shinyaku no Kaihatsu, Shinsa, Shihan go Anzentaisaku no Tsunagari ni tsuite. Pharmaceuticals and Medical Devices Agency. http://www.pmda.go.jp/guide/kagakuiinkai/iyaku/h241101gijishidai/file/shiryo2-1.pdf . Accessed 20 February 2014 (In Japanese).

4. Yakuji-hou (Pharmaceutical Affairs Act). http://law.e-gov.go.jp/htmldata/S35/S35HO145.html#1000000000010000000000000000000000000000000000000000000000000000000000000000000 . Accessed 20 February 2014 (In Japanese).

5. Yakuji-hou no ichibu wo Kaitei suru Houritsu no Gaiyou. Pharmaceuticals and Medical Devices Agency. http://www.pmda.go.jp/guide/hyougikai/25/h251226shinsaanzen2/file/sanko3.pdf . Accessed 20 February 2014 (In Japanese).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approval and Legislation Involved in Development of Medical Devices in Dentistry – A Systematic Review;Pakistan BioMedical Journal;2022-06-30

2. A Different Case of Penumbra;JAMA Internal Medicine;2022-05-01

3. Regulatory affairs for chemistry, manufacturing, and controls;Regulatory Affairs in the Pharmaceutical Industry;2022

4. Assessing the Risk Minimization Activity in Risk Management Plans for Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2);Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2021-09-10

5. Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review;European Journal of Clinical Pharmacology;2021-04-07